NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • About Patient and Public Involvement
      • Our Work with Patients and the Public
      • Learn More About Our Research
      • Patient Involvement Blog
      • External Links
    • For Patients, Carers and the Public
      • Current Listings for Involvement
      • REGISTER INTEREST
      • Patient and Public Involvement Workshops
    • PPI Resources for Researchers
      • PPI Strategy
      • A Researcher’s Guide to PPI
      • PPI Resources for Researchers
      • PPI Briefing Notes
      • PPI Case Studies
      • PPI Advisory Group
      • PPI Events for Researchers
      • Post a PPI Listing
      • Public Engagement for Researchers
      • Public Engagement Case Studies
  • Training Hub
    • Training Hub
    • Fellowships
    • Funding Opportunities
    • Clinical Researchers and Scientists
    • Nurses, Midwives and Allied Health Professionals
    • Next Generation Leaders Programme
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Other News > Change at the helm of Oxford Biomedical Research Centre

Change at the helm of Oxford Biomedical Research Centre

29 August 2018 · Listed under Other News

The leading academic who has overseen the expansion of world-leading medical research at the NIHR Oxford Biomedical Research Centre (BRC) for the past nine years is stepping down. Professor Keith Channon will be replaced as Director of the Oxford BRC by Professor Helen McShane, a leading vaccine specialist.

Prof Channon was appointed to lead the BRC, one of the National Institute of Health Research’s largest research centres, in 2009. He has overseen two successful bids for government funding to carry out research that benefits NHS patients: for £95.5m in 2012; and £113.7m for the period from 2017 to 2022, to support research across 20 medical themes.

The NIHR Oxford BRC is based at Oxford University Hospitals (OUH) NHS Foundation Trust and run in partnership with the University of Oxford.

Prof Channon, a leading cardiologist, will continue in his role of Director of Research and Development for OUH, and take up a new role as Deputy Head of the University’s Medical Sciences Division for Research.

Prof Channon said: “It has been a privilege to lead the NIHR Oxford BRC for the past nine years and oversee the expansion of the work we do to drive clinical innovation.

“I am proud of the fact that our BRC has consistently been rewarded for its excellence with increased funding. This is in recognition of the world class research that is done here and that is having real tangible benefits for patients across a wide range of medical fields.

“I am confident that Helen will be able to play her part in maintaining Oxford’s position at the forefront of global medical research.”

Prof McShane is Professor of Vaccinology in the University of Oxford’s Nuffield Department of Medicine, based at the Jenner Institute, and is an Honorary Consultant Physician in HIV and genito-urinary medicine at the Oxford University Hospitals. She is a previous Wellcome Trust Senior Research Fellow with an international reputation in clinical research and clinical trials in TB infection and vaccines. She has been an important contributor to the Oxford BRCs Vaccines Theme, and was awarded a BRC Principal Fellowship in 2016.

Prof McShane said: “It is a great honour to have been appointed to lead the Oxford BRC and am very excited about taking up this pivotal role for medical research in Oxford. Keith has been an outstanding champion of the BRC’s research and I am looking forward to taking up the baton from him.

“I have a background in translational medicine in the field of vaccine development and have a real passion for ensuring that the research we do leads to real benefits for patients. It is a real privilege, then, to be in a position where I can help to make this happen.”

Dr Bruno Holthof, Chief Executive Officer of Oxford University Hospitals, said: “Keith’s diligence and vision have ensured that Oxford has remained a hub of medical innovation with one of the largest clinical trial portfolios in the UK. I would like to thank him for all his immense contribution to making our hospitals a centre of research excellence.

“We are the only BRC to have successively increased our funding, and that’s a reflection of the world-leading innovation that takes place here in disciplines as diverse as cancer, diabetes, genetics, microbiology, neuroscience or big data. Keith has done a fantastic job in coordinating that research and ensuring that the relationship between academics and clinicians remains vibrant and strong.”

He continued: “Prof McShane’s appointment as the new BRC Director will assure that the Oxford BRC remains at the forefront of basic science and patient-based clinical research, and that we continue to develop our Hospital-University partnership to achieve both research excellence and benefits for patients.”

← Controlling infection essential to tackle global anaemia
Event explores Healthcare Technologies of the Future →

News

  • Oxford academics named NIHR Senior Investigators 3 March 2021
  • New centre aims to help companies conduct more efficient trials 26 February 2021
  • Oxford study reveals public attitudes to vaccine roll-out programmes 23 February 2021
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2021 NIHR Oxford Biomedical Research Centre

Cookies

This site uses cookies See our data control and privacy page